1. Sherman LA. Looking through a window of the Food and Drug Administration: FDA’s advisory committee system. Preclinica. 2004;2:99–102.
2. Roden DM, Temple R. The US food and drug administration cardiorenal advisory panel and the drug approval process. Circulation. 2005;111:1697–1702.
3. U.S. Department of Health and Human Services. Food and Drug Administration. Innovation or Stagnation. Challenge and opportunity on the Critical path to New Medical Products. Available at: http://www.fda.gov/oc/initatives/criticalpath/whitepaper.html. Accessed December 27, 2005.
4. FDA Web site. Available at: http://www.fda.com. The list of 2004 advisory committee meetings is available at: http://www.fda.gov/ohrms/dockets/ac/05acdocs.htm.
5. Available at: http://finance.yahoo.com.